National Health Investors, Inc. (NHI)

Import this data to Google Sheets with:

=jivedata("NHI","financials")

Full statements spill as a table. For one cell: =jivedata("NHI","Revenue") or =jivedata("NHI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

National Health Investors, Inc.

NHI • CIK 0000877860

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Lease Income	$249,227	$257,049	$271,600	$277,004
Revenue from Contract with Customer, Excluding Assessed Tax	$48,809	$54,421	$80,062	$133,745
Interest and Fee Income, Loans and Leases	$21,799	$23,711	$23,966	$21,370
Gain (Loss) on Termination of Lease	$20	$0	$0	$0
Revenues	$319,835	$335,181	$375,628	$432,119
Gains (Losses) on Sales of Investment Real Estate	$14,721	$6,678	$456	$24,811
Income (Loss) from Equity Method Investments	$555	$402	$3,664	$1,725
Gain (Loss) on Extinguishment of Debt	$-73	$0	$0	$0
Gain (Loss) on Sale of Derivatives	—	$6,261	$0	$0
Other Nonoperating Income	—	—	$0	$121
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$134,381	$136,639	$140,787	$165,390
Net Income (Loss) Attributable to Noncontrolling Interest	$-1,273	$-1,346	$-1,390	$-1,408
Net Income (Loss) Attributable to Parent	$135,654	$137,985	$142,177	$166,798
Other Preferred Stock Dividends and Adjustments	$57	$118	$201	$201
Net Income (Loss) Available to Common Stockholders, Basic	$135,597	$137,867	$141,976	$166,525
Depreciation, Depletion and Amortization, Nonproduction	—	—	$80,944	$91,108
InterestExpenseOperating	—	$59,903	$57,368	$58,884
General and Administrative Expense	$19,314	$20,736	$26,868	$30,588
Legal Fees	—	—	$1,572	$0
Real Estate Taxes and Insurance	$11,513	$11,165	$10,982	$10,727
Operating Expenses	$200,879	$211,883	$238,961	$292,654
Weighted Average Number of Shares Outstanding, Basic	43,388,794	43,844,771	46,874,691	49,048,396
Weighted Average Number of Shares Outstanding, Diluted	43,389,466	44,102,636	47,051,763	49,224,303
Net Income (Loss) Available to Common Stockholders, Diluted	—	$137,867	$141,976	$166,525
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	802,506	235,344	41,377	220,321
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	672	184,416	132,982	74,695
Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements	—	73,449	44,090	101,212

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Land	$180,749	$191,909	$221,660	$232,660
Investment Building and Building Improvements	$2,593,696	$2,751,071	$3,055,866	$3,055,866
Construction in Progress, Gross	$5,913	$10,568	$18,214	$19,336
Property, Plant and Equipment, Gross	$2,780,358	$2,953,548	$3,295,740	$3,282,842
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$673,276	$742,295	$821,982	$716,370
Property, Plant and Equipment, Net	$2,107,082	$2,211,253	$2,473,758	$2,566,472
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	$245,271	$268,926	$203,296	$209,273
Cash and Cash Equivalents, at Carrying Value	$22,347	$24,289	$19,624	$30,388
Deferred Rent Receivables, Net	$84,713	$87,150	$78,891	$74,997
Real Estate Held-for-sale	$5,004	$0	$3,562	$30,929
Other Assets	$24,063	$22,753	$17,756	$52,143
Assets	$2,488,480	$2,614,371	$2,796,887	$2,964,202
Redeemable Noncontrolling Interest, Equity, Carrying Amount	$9,656	$9,790	$10,195	$10,367
Debt, Long-term and Short-term, Combined Amount	$1,135,051	$1,146,041	$1,163,814	$1,274,522
Accounts Payable and Accrued Liabilities	$34,304	$37,757	$43,734	$46,437
Dividends Payable	$39,069	$41,119	$44,439	$45,245
Deferred Revenue	$6,009	$4,277	$4,996	$4,265
Liabilities	$1,214,433	$1,229,194	$1,256,983	$1,374,945
Common Stock, Value, Issued	$434	$457	$483	$491
Additional Paid in Capital, Common Stock	$1,603,757	$1,736,831	$1,922,713	$1,966,642
Retained Earnings (Accumulated Deficit)	$2,466,844	$2,604,829	$2,747,006	$2,842,779
Cumulative Dividends	$2,817,083	$2,975,642	$3,148,659	$3,238,486
Stockholders' Equity Attributable to Parent	$1,253,952	$1,366,475	$1,521,543	$1,571,426
Stockholders' Equity Attributable to Noncontrolling Interest	$10,439	$8,912	$8,166	$7,464
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,264,391	$1,375,387	$1,529,709	$1,578,890
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	$15,476	$20,249	$15,397	$15,264
Common Stock, Shares Authorized	100,000,000	100,000,000,000	100,000,000,000	100,000,000
Common Stock, Shares, Issued	43,409,841	45,687,942	48,302,944	49,115,748
Off-Balance Sheet, Credit Loss, Liability	$279	$147	$152	$176
Off-Balance Sheet, Credit Loss, Liability, Credit Loss Expense (Reversal)	$-404	$-132	$5	$24

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$134,381	$136,639	$140,787	$165,390
Net Cash Provided by (Used in) Operating Activities	$184,450	$207,768	$236,563	$248,681
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$3,101	$1,885	$-6,878	$31,111
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$24,617	$26,502	$19,624	$-92,705
Depreciation, Depletion and Amortization, Nonproduction	—	—	$80,944	$91,108
Payments to Acquire Real Estate	$38,081	$138,128	$274,068	$372,970
Amortization of Deferred Loan Origination Fees, Net	$412	$116	$920	$882
Proceeds from Sale of Wholly Owned Real Estate and Real Estate Acquired in Settlement of Loans	$57,031	$6,179	$0	$92,961
Amortization of Debt Issuance Costs	$4,685	$6,583	$3,427	$1,781
Payments to Acquire Mortgage Notes Receivable	$35,625	$60,412	$71,110	$57,598
Proceeds from Sale and Collection of Mortgage Notes Receivable	$13,465	$19,365	$92,331	$69,899
Share-based Payment Arrangement, Expense	$4,605	$4,182	$5,576	$6,547
Proceeds from Equity Method Investment, Distribution, Return of Capital	$3,055	$402	$3,664	$1,725
Net Cash Provided by (Used in) Investing Activities	$-11,630	$-192,315	$-269,149	$-292,664
Straight Line Rent	$6,961	$3,031	$-7,265	$-8,389
Other Noncash Income	$1,302	$124	$1,735	$1,734
Gains (Losses) on Sales of Investment Real Estate	$14,721	$6,678	$456	$24,811
Income (Loss) from Equity Method Investments	$555	$402	$3,664	$1,725
Gain (Loss) on Extinguishment of Debt	$-73	$0	$0	$0
Proceeds from Lines of Credit	$364,000	$449,700	$694,000	$814,000
Repayments of Lines of Credit	$161,000	$363,500	$821,200	$754,000
Proceeds from Bank Debt	$200,000	$0	$0	$0
Repayments of Long-term Debt	$415,427	$75,436	$200,815	$250,000
Proceeds from Issuance of Senior Long-term Debt	$0	—	$346,161	$346,161
Payments of Debt Issuance Costs	$2,747	$3,486	$3,881	$3,696
Proceeds from Issuance of Common Stock	$0	$142,394	$181,533	$102,983
Payments of Stock Issuance Costs	$0	$930	$767	$1,028
Proceeds from Noncontrolling Interests	$2,973	$1,170	$1,746	$2,390
Payments to Noncontrolling Interests	$1,280	$1,151	$917	$692
Payments of Dividends	$156,238	$156,510	$169,696	$175,574
Payment, Tax Withholding, Share-based Payment Arrangement	$0	$5,819	$456	$5,450
Net Cash Provided by (Used in) Financing Activities	$-169,719	$-13,568	$25,708	$75,094
Interest Paid, Excluding Capitalized Interest, Operating Activities	$51,897	$55,374	$51,497	$50,208
Fair Value of Assets Acquired	—	—	$50,800	$50,800
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed	—	—	$778	$778
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$101	$344	$139	$2,241
Noncash or Part Noncash Acquisition, Payables Assumed	—	$189	$0	$0
Increase (Decrease) in Prepaid Expense and Other Assets	$2,743	$4,700	$-57	$10,769
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$5,929	$3,285	$5,490	$13,418
Increase (Decrease) in Deferred Revenue	$101	$-1,140	$1,713	$1,585

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("NHI","financials")

Full statements spill as a table. For one cell: =jivedata("NHI","Revenue") or =jivedata("NHI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.